Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report

RATIONALE: Lung cancer is the leading cause of cancer-associated deaths all over the world. Although the prognosis of lung cancer has improved over the past decade due to progression in surgical techniques and systematic treatments, the patients with advanced disease still suffer poor survival. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Zheng, Yulong, Xu, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380768/
https://www.ncbi.nlm.nih.gov/pubmed/30702616
http://dx.doi.org/10.1097/MD.0000000000014328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380768/
https://www.ncbi.nlm.nih.gov/pubmed/30702616
http://dx.doi.org/10.1097/MD.0000000000014328

Ejemplares similares